共 297 条
- [1] Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249
- [2] Ferlay J(2010)Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial Lancet Oncol 11 439-449
- [3] Siegel RL(2006)Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11-20
- [4] Laversanne M(2021)First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial The Lancet 398 27-40
- [5] Soerjomataram I(2004)Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma J Clin Oncol 22 2774-2780
- [6] Jemal A(2021)PRODIGY: a phase III study of neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 versus surgery and adjuvant S-1 for resectable advanced gastric cancer J Clin Oncol 39 2903-2913
- [7] Bray F(2018)Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: analysis of the National Cancer Data Base, 2006–2014 Cancer 124 998-1007
- [8] Songun I(2014)Comprehensive molecular characterization of gastric adenocarcinoma Nature 513 202-209
- [9] Putter H(2020)Gastric cancer The Lancet 396 635-648
- [10] Kranenbarg EM-K(2009)Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer Oncology 77 197-204